National Bank of Canada
AGTC

National Bank of Canada’s Applied Genetic Technologies Corporation AGTC Stock Holding History

National Bank of Canada’s Portfolio AGTC Stock Details AGTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,700
Closed – – 2973
2022
Q3 		$0 Hold
1,700
– – ﹤0.01% 2969
2022
Q2 		$1K Hold
1,700
– – ﹤0.01% 2754
2022
Q1 		$2K Hold
1,700
– – ﹤0.01% 2745
2021
Q4 		$3K Buy
+1,700
New +$4.07K ﹤0.01% 2657

National Bank of Canada's AGTC Position: Q4 2022 in Review

National Bank of Canada sold out of Applied Genetic Technologies Corporation (AGTC) in Q4 2022, closing a stake of 1,700 shares.

National Bank of Canada first reported a position in AGTC in Q4 2021 and held it in 4 quarters. The position peaked at $3K in Q4 2021. 0 funds tracked by Wall St. Rank hold AGTC as of Q4 2022.

  • National Bank of Canada reported no remaining Applied Genetic Technologies Corporation position as of Q4 2022 after selling out during the quarter.
  • National Bank of Canada sold 1,700 Applied Genetic Technologies Corporation shares in Q4 2022.
  • National Bank of Canada first reported a position in Applied Genetic Technologies Corporation in Q4 2021 and held it in 4 quarters.
  • National Bank of Canada's Applied Genetic Technologies Corporation position peaked at $3K in Q4 2021.
  • 0 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q4 2022.

Based on National Bank of Canada's 13F filing for Q4 2022, filed 24 Jan 2023.